{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:28:57Z","timestamp":1790882937602,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.joms.2020.06.016","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T15:59:44Z","timestamp":1592063984000},"page":"2226-2234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Positive Outcomes of Denosumab Treatment in 2 Patients With Cherubism"],"prefix":"10.1016","volume":"78","author":[{"given":"Eitan","family":"Bar Droma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Beck-Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoly","family":"Ilgiyaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yariv","family":"Fruchtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Abramovitch-Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Levaot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navot","family":"Givol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2020.06.016_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.humpath.2016.07.019","article-title":"Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism","volume":"58","author":"Kadlub","year":"2016","journal-title":"Hum Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.joms.2020.06.016_bib2","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1750-1172-7-S1-S6","article-title":"Cherubism: Best clinical practice","volume":"7","author":"Papadaki","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.joms.2020.06.016_bib3","first-page":"589","article-title":"Expression of c-Src and comparison of cytologic features in cherubism, central giant cell granuloma and giant cell tumors","volume":"15","author":"Wang","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.joms.2020.06.016_bib4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1054\/bjps.2001.3701","article-title":"Cherubism and its charlatans","volume":"54","author":"Lannon","year":"2001","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.joms.2020.06.016_bib5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0039-1698923","article-title":"Treatment of cherubism with salmon calcitonin: A case report","volume":"5","author":"Etoz","year":"2011","journal-title":"Eur J Dent"},{"key":"10.1016\/j.joms.2020.06.016_bib6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jbmr.2431","article-title":"The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism","volume":"30","author":"Kadlub","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2020.06.016_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bone.2012.10.003","article-title":"Anti-tumor necrosis factor treatment in cherubism\u2014Clinical, radiological and histological findings in two children","volume":"52","author":"Hero","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.joms.2020.06.016_bib8","doi-asserted-by":"crossref","first-page":"1278.e1","DOI":"10.1016\/j.joms.2019.02.021","article-title":"A paradigm shift in the management of cherubism? A preliminary report using imatinib","volume":"77","author":"Ricalde","year":"2019","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2020.06.016_bib9","doi-asserted-by":"crossref","first-page":"e10210","DOI":"10.1002\/jbm4.10210","article-title":"Use of denosumab in children with osteoclast bone dysplasias: Report of three cases","volume":"3","author":"Upfill-Brown","year":"2019","journal-title":"JBMR Plus"},{"key":"10.1016\/j.joms.2020.06.016_bib10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/17401","article-title":"Cyclosporine induces cancer progression by a cell-autonomous mechanism","volume":"397","author":"Hojo","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.joms.2020.06.016_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00198-015-3339-z","article-title":"Does salmon calcitonin cause cancer? A review and meta-analysis","volume":"27","author":"Wells","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joms.2020.06.016_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/88832","article-title":"Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism","volume":"28","author":"Ueki","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.joms.2020.06.016_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cell.2006.10.047","article-title":"Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 \"cherubism\" mice","volume":"128","author":"Ueki","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.joms.2020.06.016_bib14","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1172\/JCI45843","article-title":"3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions","volume":"121","author":"Levaot","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.joms.2020.06.016_bib15","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2011.10.045","article-title":"Loss of tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism","volume":"147","author":"Levaot","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.joms.2020.06.016_bib16","doi-asserted-by":"crossref","first-page":"20952","DOI":"10.1074\/jbc.M109.091124","article-title":"3BP2 adapter protein is required for receptor activator of NF kappa B ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells","volume":"285","author":"Guez Guez","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.joms.2020.06.016_bib17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jclinpath-2015-203248","article-title":"Denosumab treated giant cell tumour of bone: A morphological, immunohistochemical and molecular analysis of a series","volume":"69","author":"Girolami","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.joms.2020.06.016_bib18","first-page":"208","article-title":"Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system","volume":"30","author":"Tanaka","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.joms.2020.06.016_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","article-title":"Denosumab in patients with giant-cell tumour of bone: An open-label, phase 2 study","volume":"11","author":"Thomas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.joms.2020.06.016_bib20","doi-asserted-by":"crossref","first-page":"115048","DOI":"10.1016\/j.bone.2019.115048","article-title":"Off-label uses of denosumab in metabolic bone diseases","volume":"129","author":"Polyzos","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.joms.2020.06.016_bib21","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"Boyce","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2020.06.016_bib22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00247-020-04651-y","article-title":"Dense sclerotic metaphyseal bands caused by denosumab therapy","volume":"50","author":"Dunnion","year":"2020","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.joms.2020.06.016_bib23","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2014-3072","article-title":"Effect of denosumab on the growing skeleton in osteogenesis imperfecta","volume":"99","author":"Hoyer-Kuhn","year":"2014","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239120305905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239120305905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:03:28Z","timestamp":1759511008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239120305905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0278239120305905"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2020.06.016","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive Outcomes of Denosumab Treatment in 2 Patients With Cherubism","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2020.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}